Today: 19 June 2026
Browse Category

Earnings Reports 26 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
Amphenol stock price jumps as APH heads into Q4 earnings and a Fed-packed week

Amphenol stock price jumps as APH heads into Q4 earnings and a Fed-packed week

Amphenol shares rose 3% to close at $155.53 on Monday, outpacing the S&P 500 ahead of its fourth-quarter earnings release set for Wednesday. The move follows the company’s recent $4.1 billion acquisition of CommScope’s Connectivity and Cable Solutions business. Investors are also watching for the Federal Reserve’s rate decision on Jan. 28.
26 January 2026
······
Arista Networks stock jumps 5% as traders eye Fed week and Feb. 12 earnings

Arista Networks stock jumps 5% as traders eye Fed week and Feb. 12 earnings

Arista Networks shares rose 5.4% to $143.70 Monday, nearing last week’s high amid renewed tech buying ahead of major earnings and a Federal Reserve decision. Options activity and anticipation of Arista’s Feb. 12 earnings report drove trading. Investors are watching for 2026 demand signals and updates on AI-related orders. U.S. stocks edged higher as traders weighed megacap and AI names.
26 January 2026
···
Starbucks stock slips as SBUX nears earnings and Investor Day — what traders are watching

Starbucks stock slips as SBUX nears earnings and Investor Day — what traders are watching

Starbucks shares fell 1.4% to $96.22 Monday, trailing a broader market rally ahead of its fiscal Q1 earnings report Wednesday and Investor Day Thursday. Volume reached 8.1 million shares. Analysts cited steady sales but ongoing margin pressures from higher coffee and labor costs. Peers traded mixed, with McDonald’s up 1.1% and Dutch Bros down 2.8%.
26 January 2026
··
Cloudflare stock jumps on viral ‘Clawdbot’ AI-agent buzz as Wall Street eyes Feb. 10 earnings

Cloudflare stock jumps on viral ‘Clawdbot’ AI-agent buzz as Wall Street eyes Feb. 10 earnings

Cloudflare shares surged 11.5% to $193.30 Monday, outpacing sector rivals after social media buzz around “Clawdbot,” an open-source AI agent built on Anthropic’s Claude. Wolfe Research linked the rally to expectations that Cloudflare’s network could benefit if AI-driven traffic rises. Investors await Cloudflare’s Feb. 10 earnings and the Federal Reserve’s policy decision this week. Akamai, Fastly, and Zscaler also posted gains.
26 January 2026
···
Pfizer stock edges up as traders brace for Feb. 3 earnings and a Fed decision

Pfizer stock edges up as traders brace for Feb. 3 earnings and a Fed decision

Pfizer shares rose 0.7% to $25.84 in Monday afternoon trading, tracking a broader U.S. stock rally ahead of major earnings and a Federal Reserve policy decision. Investors are watching for Pfizer’s Feb. 3 earnings and updates on its 2026 outlook, as the company faces falling COVID demand and looming patent expirations. Trading volume remained moderate, with no major company news released.
26 January 2026
····
Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings

Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings

Boston Scientific shares rose 1.7% to $94.12 Monday, outpacing medical-device peers and the S&P 500. Evercore reaffirmed its Outperform rating and $112 target, dismissing concerns about the $14.5 billion Penumbra acquisition. Investors await the Feb. 4 earnings call for updates on integration, financing, and demand trends. The Penumbra deal is expected to close in 2026.
26 January 2026
··
Texas Instruments stock price rises ahead of Q4 earnings — what could move TXN next

Texas Instruments stock price rises ahead of Q4 earnings — what could move TXN next

Texas Instruments shares rose 1.5% to $196.20 Monday, outpacing a flat semiconductor sector ahead of its quarterly earnings report due Tuesday after markets close. Analysts expect EPS of $1.29 on $4.44 billion revenue. CEO Haviv Ilan and CFO Rafael Lizardi will lead the earnings call at 3:30 p.m. Central. Investors are watching for signs of recovery in industrial and automotive chip demand.
26 January 2026
··
AbbVie stock price edges up: what investors watch ahead of Feb. 4 earnings

AbbVie stock price edges up: what investors watch ahead of Feb. 4 earnings

AbbVie shares rose 0.4% to $220.10 Monday, moving between $217.15 and $221.48 as investors awaited its Feb. 4 earnings report. Health-care stocks held firm, with the sector ETF up 0.4% and Johnson & Johnson and Pfizer also gaining. AbbVie’s upcoming results will highlight its immunology drugs as it faces pressure from declining Humira sales and recent policy deals. Traders are watching Wednesday’s Fed decision before the earnings release.
26 January 2026
···
GE Vernova stock price rises as Morgan Stanley trims target ahead of earnings

GE Vernova stock price rises as Morgan Stanley trims target ahead of earnings

GE Vernova shares rose 1.7% to $669.04 Monday afternoon ahead of its quarterly earnings report, due before markets open Jan. 28. Morgan Stanley maintained an Overweight rating but lowered its price target to $817. Wall Street expects earnings of $3.03 per share on $10.04 billion revenue. The report coincides with the Federal Reserve’s policy decision Wednesday.
26 January 2026
··
Caterpillar stock climbs in New York as CAT traders brace for earnings, Fed week

Caterpillar stock climbs in New York as CAT traders brace for earnings, Fed week

Caterpillar shares rose 1.7% to $637.22 Monday, with 1.3 million shares traded ahead of its Jan. 29 earnings report. Analysts expect higher revenue but lower profit, projecting $4.67 per share on $17.89 billion. Options pricing signals a possible 6% move after results. The Federal Reserve’s Jan. 27-28 meeting and ongoing tariffs add uncertainty for machinery stocks.
26 January 2026
···
Coca-Cola stock price barely moves today as Fed week and earnings loom

Coca-Cola stock price barely moves today as Fed week and earnings loom

Coca-Cola shares slipped 0.1% to $72.83 Monday afternoon as investors awaited the Federal Reserve’s Jan. 27-28 policy decision. The broader consumer staples sector also declined, while PepsiCo rose 0.7%. Coca-Cola will report fourth-quarter and full-year results on Feb. 10. The company recently announced leadership changes, including a new chief digital officer.
26 January 2026
···
Dow Jones today: Apple, Cisco lift the index as Fed decision and Big Tech earnings loom

Dow Jones today: Apple, Cisco lift the index as Fed decision and Big Tech earnings loom

The Dow Jones rose 0.6% to 49,403 Monday afternoon, led by Apple and Cisco, while UnitedHealth and 3M lagged. Gold and silver hit new records as the dollar weakened. The Federal Reserve begins a two-day meeting Tuesday, with rates expected to hold steady. Investors await earnings from major tech firms and the Fed’s decision Wednesday.
26 January 2026
·········
Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher shares rose 0.8% to $631.24 by midday Monday in New York, rebounding from an early dip ahead of Thursday’s earnings report and 2026 outlook. Options markets point to an expected 4% swing after results. Analysts forecast Q4 earnings of $6.43 per share, up from $6.10 a year ago. The company will hold its earnings call at 8:30 a.m. ET on Jan. 29.
26 January 2026
··
SoFi stock price ticks higher as traders brace for Friday earnings and the Fed

SoFi stock price ticks higher as traders brace for Friday earnings and the Fed

SoFi Technologies shares rose 0.6% to $26.00 by midday Monday, with about 19 million shares traded. Investors are watching for SoFi’s Q4 and full-year earnings Friday and the Federal Reserve’s policy decision Wednesday. Peers showed mixed moves, with Affirm down and Upstart, PayPal up slightly. The Fed is expected to hold rates steady at 3.50%–3.75%.
26 January 2026
···
1 … 103 104 105 106 107 … 257

Stock Market Today

  • Electro Optic Systems Expands AI Counter-Drone Operations with New European Hub and US Orders
    June 18, 2026, 10:26 PM EDT. Electro Optic Systems Holdings (ASX:EOS) has committed over €10 million to create a European AI-enabled counter-drone hub in Nice, France, while securing its first 100kW-class laser weapon export to the Netherlands and a US$5 million counter-drone order from US defense contractor L3Harris. This move broadens the company's footprint in advanced defense technologies, supporting a near-term revenue pipeline amid ongoing risks including reliance on large contracts and potential capital raises. EOS recently raised A$40 million through equity to fund expansion and product delivery. Forecasts project EOS revenue at A$514.7 million and earnings of A$62.6 million by 2029, implying a 39% share price upside to a A$12.94 fair value. Investors must balance growth potential against execution and dilution risks in this evolving defense sector player.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop